Skip to content
Search Classifications
Search for IPC and CPC classification codes or keywords
CPC Main Group Additional Only
A61L 2400/00

Materials characterised by their function or physical properties

9 direct subcodes

Child Classifications

Navigate with arrow keys, Enter to open

  • A61L 2400/02 Treatment of implants to prevent calcification or mineralisation in vivo
  • A61L 2400/04 Materials for stopping bleeding
  • A61L 2400/06 Flowable or injectable implant compositions
  • A61L 2400/08 Methods for forming porous structures using a negative form which is filled and then removed by pyrolysis or dissolution
  • A61L 2400/10 Materials for lubricating medical devices
  • A61L 2400/12 Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
  • A61L 2400/14 Adhesives for ostomy devices
  • A61L 2400/16 Materials with shape-memory or superelastic properties
  • A61L 2400/18 Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment

Top Applicants

Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT

  1. PHILIPS ELECTRONICS NL 20,621
  2. NOVARTIS CH 15,792
  3. ROCHE CH 14,303
  4. COVIDIEN US 13,862
  5. HARVARD UNIVERSITY US 13,454
  6. UNIVERSITY OF CALIFORNIA US 12,798
  7. P&G (PROCTER & GAMBLE COMPANY) US 12,140
  8. L'OREAL FR 11,800
  9. OLYMPUS CORPORATION JP 9,894
  10. BOSTON SCIENTIFIC SCIMED US 9,513